These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10196103)

  • 1. Irreversible caspase inhibitors: tools for studying apoptosis.
    Wu JC; Fritz LC
    Methods; 1999 Apr; 17(4):320-8. PubMed ID: 10196103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.
    Berger AB; Witte MD; Denault JB; Sadaghiani AM; Sexton KM; Salvesen GS; Bogyo M
    Mol Cell; 2006 Aug; 23(4):509-21. PubMed ID: 16916639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells.
    Gamen S; Anel A; Pérez-Galán P; Lasierra P; Johnson D; Piñeiro A; Naval J
    Exp Cell Res; 2000 Jul; 258(1):223-35. PubMed ID: 10912804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-1 is not involved in CD95/Fas-induced apoptosis in Jurkat T cells.
    Chow SC; Slee EA; MacFarlane M; Cohen GM
    Exp Cell Res; 1999 Feb; 246(2):491-500. PubMed ID: 9925765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
    Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and biophysical characterization of inhibitor binding to caspase-3 reveals induced asymmetry.
    Aulabaugh A; Kapoor B; Huang X; Dollings P; Hum WT; Banker A; Wood A; Ellestad G
    Biochemistry; 2007 Aug; 46(33):9462-71. PubMed ID: 17649976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
    Mathiasen IS; Lademann U; Jäättelä M
    Cancer Res; 1999 Oct; 59(19):4848-56. PubMed ID: 10519395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bimodal inhibition of caspase-1 by aryloxymethyl and acyloxymethyl ketones.
    Brady KD
    Biochemistry; 1998 Jun; 37(23):8508-15. PubMed ID: 9622503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO.
    Yoshimori A; Sakai J; Sunaga S; Kobayashi T; Takahashi S; Okita N; Takasawa R; Tanuma S
    BMC Pharmacol; 2007 Jun; 7():8. PubMed ID: 17594508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
    Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR
    Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D4-GDI is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells.
    Kwon KB; Park EK; Ryu DG; Park BH
    Exp Mol Med; 2002 Mar; 34(1):32-7. PubMed ID: 11989976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncovalent tripeptidyl benzyl- and cyclohexyl-amine inhibitors of the cysteine protease caspase-1.
    Löser R; Abbenante G; Madala PK; Halili M; Le GT; Fairlie DP
    J Med Chem; 2010 Mar; 53(6):2651-5. PubMed ID: 20170165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of human caspase-6 in complex with Z-VAD-FMK: New peptide binding mode observed for the non-canonical caspase conformation.
    Müller I; Lamers MB; Ritchie AJ; Dominguez C; Munoz-Sanjuan I; Kiselyov A
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5244-7. PubMed ID: 21820899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2.
    Guo H; Tittle TV; Allen H; Maziarz RT
    Exp Cell Res; 1998 Nov; 245(1):57-68. PubMed ID: 9828101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
    Valente C; Moreira R; Guedes RC; Iley J; Jaffar M; Douglas KT
    Bioorg Med Chem; 2007 Aug; 15(15):5340-50. PubMed ID: 17532221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors.
    Wang Z; Watt W; Brooks NA; Harris MS; Urban J; Boatman D; McMillan M; Kahn M; Heinrikson RL; Finzel BC; Wittwer AJ; Blinn J; Kamtekar S; Tomasselli AG
    Biochim Biophys Acta; 2010 Sep; 1804(9):1817-31. PubMed ID: 20580860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes.
    Drénou B; Blancheteau V; Burgess DH; Fauchet R; Charron DJ; Mooney NA
    J Immunol; 1999 Oct; 163(8):4115-24. PubMed ID: 10510346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity.
    Pereira NA; Song Z
    Biochem Biophys Res Commun; 2008 Dec; 377(3):873-7. PubMed ID: 18976637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of diacetoxyscirpenol is associated with apoptosis by activation of caspase-8 and interruption of cell cycle progression by down-regulation of cdk4 and cyclin B1 in human Jurkat T cells.
    Jun DY; Kim JS; Park HS; Song WS; Bae YS; Kim YH
    Toxicol Appl Pharmacol; 2007 Jul; 222(2):190-201. PubMed ID: 17559898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis.
    Fattman CL; Delach SM; Dou QP; Johnson DE
    Oncogene; 2001 May; 20(23):2918-26. PubMed ID: 11420704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.